Provided by Tiger Fintech (Singapore) Pte. Ltd.

CHINARES PHARMA

5.210
+0.0100.19%
Volume:22.13M
Turnover:114.91M
Market Cap:32.73B
PE:9.22
High:5.220
Open:5.200
Low:5.120
Close:5.200
Loading ...

Stock Track | China Resources Pharmaceutical Plummets 5.13% Following Disappointing 2024 Profit Results

Stock Track
·
26 Mar

China Resources Pharmaceutical's 2024 Profit Slides; Shares Fall 4%

MT Newswires Live
·
26 Mar

BRIEF-China Resources Pharmaceutical Says FY Net Profit Attributable For Jiangzhong Pharmaceutical Was RMB788.2 Million

Reuters
·
19 Mar

China Resources Pharmaceutical - Cash Dividend of RMB7.00 for Every 10 Shares of Jiangzhong Pharmaceutical

THOMSON REUTERS
·
19 Mar

BRIEF-China Resources Pharmaceutical Posts FY Results For CR Double-Crane Pharmaceutical

Reuters
·
19 Mar

China Resources Pharmaceutical - FY Net Profit Attributable for China Resources Double-Crane Pharmaceutical RMB1.63 Bln

THOMSON REUTERS
·
19 Mar

China Resources Pharmaceutical Posts FY Net Profit Attributable Of CR Boya Bio-Pharmaceutical Of RMB397 Million

Reuters
·
18 Mar

China Resources Pharmaceutical - FY Net Profit Attributable of Cr Boya Bio-Pharmaceutical RMB397 Mln

THOMSON REUTERS
·
18 Mar

China Resources Pharmaceutical Posts FY Revenue RMB5.92 Bln For Dong-E-E-Jiao

Reuters
·
18 Mar

China Resources Pharmaceutical - FY Net Profit Attributable for Dong-E-E-Jiao RMB1.56 Bln

THOMSON REUTERS
·
17 Mar

CR Sanjiu Logs 18% Boost in 2024 Profit

MT Newswires Live
·
13 Mar

KPC Pharmaceuticals' 2024 Profit Rises 20%

MT Newswires Live
·
12 Mar

China Resources Pharmaceutical Group Limited's (HKG:3320) Shares May Have Run Too Fast Too Soon

Simply Wall St.
·
11 Feb

KPC Pharmaceuticals Records 46% Higher Net Attributable Profit in 2024

MT Newswires Live
·
10 Feb

China Resources Pharmaceutical's Shenzhen Listed Subsidiary Records 18% Higher Net Attributable Profit for 2024

MT Newswires Live
·
10 Feb

Jiang Zhong Pharmaceutical Logs 9% Increase in 2024 Profit

MT Newswires Live
·
27 Jan

BRIEF-China Resources Pharmaceutical Sees Net Profit Attributable RMB784.9 Mln For Jiangzhong Pharmaceutical

Reuters
·
24 Jan

China Resources Pharmaceutical Sees Net Profit Attributable RMB784.9 Mln for Jiangzhong Pharmaceutical

THOMSON REUTERS
·
24 Jan

China Resources Pharmaceutical Group's Subsidiary Expects Higher Attributable Profit in 2024

MT Newswires Live
·
22 Jan

China Resources Pharmaceutical- China Resources Boya Bio-Pharmaceutical Sees Net Profit Attributable for Year RMB380.00 Mln to RMB480.00 Mln

THOMSON REUTERS
·
22 Jan